Anticoagulation self-testing after heart valve replacement

Journal of Heart Valve Disease

Volumn 11, Issue SUPPL. 1, 2002, Pages

  Rosengart, Todd K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ACCURACY; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING; CONTROLLED STUDY; HEALTH CARE COST; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; INTERNATIONAL STANDARD UNIT; LABORATORY TEST; POSTOPERATIVE CARE; PREVALENCE; PRIORITY JOURNAL; SELF EVALUATION; THROMBOEMBOLISM; VALVULAR HEART DISEASE;

ANTICOAGULANTS; EUROPE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; POSTOPERATIVE CARE; SELF CARE; UNITED STATES;

EID: 0036218987     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. The St. Jude valve prosthesis: Analysis of the clinical results in 815 implants and the need for systemic anticoagulation
2. Oral anticoagulant treatment in patients with mechanical heart valves: How to reduce the risk of thromboembolic and bleeding complications
3. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors
4. Guidelines for the management of patients with valvular heart disease: Executive summary
5. Prosthetic heart valve performance: Long-term follow-up
6. Multicenter evaluation of a new capillary blood prothrombin time monitoring system
7. A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease
8. Accuracy of laboratory and portable monitor international normalized ratio determinations. Comparison with a criterion standard
9. Patient self-management of oral anticoagulation guided by capillary (fingerstick) whole blood prothrombin times
10. Long-term patient self-management of oral anticoagulation
11. Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study
12. Outpatient use of a portable international normalized ratio/prothrombin time monitor
13. Accuracy and precision of a portable anticoagulation monitor in a clinical setting
14. Patient Self-Management of Oral Anticoagulant Therapy: An International Update
15. Optimal Frequency of Patient Monitoring and Intensity of Oral Anticoagulation Therapy in Valvular Heart Disease
16. Relationship between test frequency and outcomes of anticoagulation: A literature review and commentary with implications for the design of randomized trials of patient self-management
17. Self management of oral anticoagulant therapy after heart valve replacement
18. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation
19. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial
20. Improvement of prognosis by home prothrombin estimation in patients with life long anticoagulant therapy
21. The cost-effectiveness of different management strategies for patients on chronic warfarin therapy
22. Cost-effectiveness of self-managed anticoagulant therapy in Germany